CVE-2020-12040
This could allow an attacker that has circumvented network security measures to view sensitive non-private data or to perform a man-in-the-middle attack.
Does this matter?
High impact if exploited, but EPSS currently rates exploitation as unlikely (0.95%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.
Description
Sigma Spectrum Infusion System v's6.x (model 35700BAX) and Baxter Spectrum Infusion System Version(s) 8.x (model 35700BAX2) at the application layer uses an unauthenticated clear-text communication channel to send and receive system status and operational data. This could allow an attacker that has circumvented network security measures to view sensitive non-private data or to perform a man-in-the-middle attack.
- CVSS 3.1
- 9.8 CRITICALCVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
- EPSS
- 0.95% probability · 59th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-319
- Affected
- baxter/sigma spectrum infusion system firmware
- Source
- ics-cert@hq.dhs.gov
References
- https://www.us-cert.gov/ics/advisories/icsma-20-170-04Third Party Advisory, US Government Resource
- https://www.us-cert.gov/ics/advisories/icsma-20-170-04Third Party Advisory, US Government Resource
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.